Routine share withholding; mechanical by default.
Loading…
Traded Mar 9, 2026 · Filed Mar 11, 2026
Collegium Pharmaceutical's & General Counsel sold $228K of Collegium Pharmaceutical shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$228,110
Shares × reported transaction price
11 days after results of Feb 26, 2026, 59 days before results of May 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.7% | −0.9% | +4.7% |
| 30 days | +1.8% | +3.0% | −1.2% |
| 90 days | −0.6% | +8.9% | −9.5% |
| 180 days | −33.2% | +15.0% | −48.2% |
Past results only. Not a forecast.
Routine share withholding; mechanical by default.
Officer sold ~$488K of Collegium Pharmaceutical, Inc.
Scheduled in advanceOfficer sold ~$1.87M of Collegium Pharmaceutical, Inc.
Scheduled in advance